Yangming Cao, MD
Nephrology · Fresno
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 38 years
- Graduated 1988
Offices
2 locations · The Nephrology Group Inc · Central California Faculty Medical Group Inc
Hospitals listed: 552646 · 552702 · 552797 · 552865 · 552870 · Adventist Health Hanford · Clovis Community Medical Center · Community Regional Medical Center · Saint Agnes Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Cao’s office at (559) 459-6000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A81989 · Current
Licensed to practise in California · since 2003 · expires 2026-12-31 · Fujian Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Fresno Ambulatory Surgery Center, Inc.Ambulatory Surgery Center · Fresno, CA9.09% owner since 2016 · accredited by AAAHCAccreditation Renewed2 inspections, 1 with deficiencies · last 2021-10-27: Requirements Met
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
- American Board of Internal Medicine - Nephrology
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health HanfordHanford, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 65% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.277, Oct 2024 – Sep 2025
- Clovis Community Medical CenterClovis, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 80% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.7 (12.1 to 17.7) · 421 cases, Jan 2024 – Dec 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.692, Oct 2024 – Sep 2025
- Community Regional Medical CenterFresno, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 1 of 5 starsWorse than the national rate — Death rate among surgical inpatients with serious treatable complications: 211.21 (174.88 to 247.54) · 239 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.705, Oct 2024 – Sep 2025
- Saint Agnes Medical CenterFresno, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of Trinity Health, which runs 105 hospitals in 16 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.312, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.141, Oct 2024 – Sep 2025
See every measure and the patient survey for Adventist Health Hanford
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.277 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.9 (0 to 1.91) · 614 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.76 (0.38 to 1.15) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 190.5 (130.11 to 250.89) · 29 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 101 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.4 · 43 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.5 · 269 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.8 · 376 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.2 · 145 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.1 · 1,486 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,684 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.08 to 0.49) · 3,819 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.67 (0.36 to 4.98) · 613 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.32) · 154 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.65 (1.02 to 4.28) · 598 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.24 (0 to 16.19) · 160 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.85 (0.67 to 9.03) · 147 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 146 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.21 (0 to 1) · 3,186 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.418 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.574 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.182 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.8 · 38 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 328 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 14.5 · 302 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 22 · 380 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 407 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 113 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (10 to 17) · 896 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 228 cases | No different | Jan 2024 – Dec 2024 |
What patients said (947 patients answered, 13% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 65% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Clovis Community Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 0 better, 6 the same, 1 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.7 (12.1 to 17.7) · 421 cases | Worse | Jan 2024 – Dec 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.692 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.97 (0.04 to 1.89) · 1,840 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.16 (0.86 to 1.45) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 217.06 (167.45 to 266.67) · 84 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 69 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.1 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.4 · 161 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 14 · 507 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.6 · 798 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 336 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 3,771 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.39) · 8,649 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.08 to 0.46) · 9,146 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.46 (1.47 to 5.45) · 1,654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.19 (0.61 to 3.78) · 387 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.18 (0.7 to 3.66) · 1,578 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.47 (7.08 to 19.87) · 374 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.99 (1.37 to 8.61) · 379 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.58 (0.13 to 3.04) · 405 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.8 (0.23 to 1.38) · 8,198 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 90 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.651 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.922 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.449 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.509 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.3 · 210 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 23 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -1.5 · 152 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 58.4 · 556 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18 · 769 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.8 · 802 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (4 to 7.4) · 421 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 91 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 93 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 200 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.8 to 15.6) · 2,398 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 720 cases | No different | Jan 2024 – Dec 2024 |
What patients said (441 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Community Regional Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 0 better, 7 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 3 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 211.21 (174.88 to 247.54) · 239 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.705 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.13 (0.29 to 1.96) · 2,304 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.09 (0.87 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 116 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 187 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 445 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.2 · 399 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 582 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 3,744 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.5) · 11,052 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,566 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.33 (1.64 to 5.01) · 3,139 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.08 (0 to 2.3) · 1,423 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.7 (0.52 to 2.88) · 3,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.85 (8.11 to 15.6) · 1,481 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.4 (3.81 to 8.98) · 1,404 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.35 (0.95 to 3.76) · 760 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.64 (0.16 to 1.11) · 10,254 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.817 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.031 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.837 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.81 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 258 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 689 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 37.4 · 202 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 35.2 · 543 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.2 · 434 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.3 · 552 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.6 to 7.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.3 to 15.4) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 12.4 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.6 · 248 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.9 (9.5 to 14.9) · 2,590 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 310 cases | No different | Jan 2024 – Dec 2024 |
What patients said (421 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Saint Agnes Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 6 the same, 0 worse of 8 measures. Readmissions: 0 better, 6 the same, 3 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.312 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.141 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.18 to 1.94) · 2,342 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 197.82 (152.64 to 243.01) · 103 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.3 · 300 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.9 · 295 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.8 · 768 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.8 · 969 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 304 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 4,305 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.06 to 0.42) · 11,641 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.07 to 0.43) · 12,213 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.76 (2.91 to 6.61) · 2,466 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.09 (0 to 2.49) · 864 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.61 (0.26 to 2.96) · 2,362 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.1 (5.39 to 14.81) · 900 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.4 (1.2 to 7.59) · 882 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.84 (0.41 to 3.27) · 541 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.67 (0.14 to 1.19) · 9,626 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 58 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.835 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.182 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.004 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 412 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.6 · 1,002 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 28.8 · 296 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 25.5 · 894 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 17.8 · 981 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 1,061 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 13.4 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 412 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.3 (9.6 to 15.9) · 1,324 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 863 cases | No different | Jan 2024 – Dec 2024 |
What patients said (812 patients answered, 32% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$452,678
Medicare paid this office $452,678 for 827 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Dialysis services, 4 or more physician visits per month (20 years or older) | 82 | $113,420 | $278 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 187 | $41,759 | $92 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 143 | $33,807 | None |
| Long return visit (40+ min) | 180 | $30,775 | $77 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 179 | $26,189 | $62 |
See all 43 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 82 | $113,420 | $278 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 187 | $41,759 | $92 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 143 | $33,807 | None |
| Long return visit (40+ min) | 180 | $30,775 | $77 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 179 | $26,189 | $62 |
| Return visit (30+ min) | 231 | $25,368 | $68 |
| Home dialysis services per month (20 years or older) | 19 | $21,116 | $232 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 111 | $16,796 | $137 |
| Parathormone (parathyroid hormone) level | 178 | $15,385 | $40 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 41 | $14,079 | $231 |
| Vitamin d-3 level | 178 | $11,034 | $29 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 285 | $7,294 | $13 |
| Hemodialysis procedure with physician evaluation | 61 | $5,958 | $56 |
| Insertion of needle into vein for collection of blood sample | 211 | $5,493 | $9 |
| Cystatin c (enzyme inhibitor) level | 169 | $5,354 | $18 |
| Blood test, comprehensive group of blood chemicals | 204 | $4,897 | $10 |
| Magnesium level | 203 | $3,069 | $7 |
| Injection of drug or substance under skin or into muscle | 149 | $3,056 | $12 |
| Dialysis services, 1 physician visit per month (20 years or older) | 12 | $2,596 | $162 |
| Phosphate level | 204 | $2,182 | $5 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 18 | $2,119 | $53 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 169 | $2,024 | $6 |
| Ferritin (blood protein) level | 65 | $2,017 | $13 |
| Limited ultrasound scan behind abdominal cavity | 35 | $1,689 | $46 |
| Blood test, lipids (cholesterol and triglycerides) | 119 | $1,590 | $13 |
| Short return visit (20+ min) | 22 | $1,512 | $66 |
| Iron binding capacity | 67 | $1,294 | $9 |
| Dialysis procedure including 1 evaluation | 14 | $1,160 | $68 |
| Folic acid level, serum | 46 | $1,023 | $14 |
| Cyanocobalamin (vitamin b-12) level | 45 | $1,020 | $15 |
| Iron level | 67 | $957 | $6 |
| Creatinine level to test for kidney function or muscle injury | 112 | $798 | $5 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 15 | $621 | $39 |
| Urine microalbumin (protein) level | 77 | $577 | $6 |
| Blood count, hemoglobin | 30 | $350 | $2 |
| Red blood cell concentration measurement | 30 | $350 | $2 |
| Red blood count automated, with additional calculations | 37 | $295 | $5 |
| Total protein level, urine | 55 | $277 | $4 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 30 | $266 | $8 |
| Hemoglobin a1c level | 19 | $190 | $10 |
| Ultrasound measurement of bladder capacity after voiding | 17 | $154 | $9 |
| Uric acid level, blood | 20 | $115 | $4 |
| Infusion, normal saline solution, 250 cc | 14 | $12 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Ultrasound measurement of bladder capacity after voiding | – | – | – | – | – | 17 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
827 Original Medicare patients in 2024. Average age 73 · Under 65 18% · 85 and older 16% · Women 53% · Also on Medicaid 56% · Health risk score 4.38. Above the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 72% · Heart failure 54% · Coronary heart disease 50% · Atrial fibrillation 33% · Depression 26% · COPD 22% · Dementia 14% · Cancer 12% · Stroke 12%.
The office billed $1,810,935, Medicare allowed $577,437 and paid $452,678; for 29,702 services of 78 kinds; $62,804 of it was for drugs given in the office and $389,874 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 827 | 29,702 | 73 | 4.38 | $1,810,935 | $452,678 |
| 2023 | 797 | 36,569 | 72 | 4.06 | $1,863,394 | $469,122 |
| 2022 | 1,053 | 35,534 | 72 | 4.34 | $2,022,953 | $535,762 |
| 2021 | 1,095 | 26,222 | 71 | 4.49 | $1,843,812 | $537,478 |
| 2020 | 1,122 | 26,997 | 71 | 5.05 | $1,217,126 | $463,661 |
| 2019 | 1,388 | 15,524 | 70 | 5.36 | $1,209,821 | $638,515 |
| 2018 | 1,476 | 12,576 | 69 | 5.41 | $1,188,191 | $651,980 |
| 2017 | 1,482 | 11,486 | 69 | 5.41 | $1,147,539 | $695,787 |
| 2016 | 1,453 | 11,447 | 69 | 5.32 | $1,263,828 | $687,636 |
| 2015 | 1,385 | 10,446 | 69 | 4.73 | $1,131,950 | $621,123 |
| 2014 | 1,453 | 10,411 | 70 | 4.15 | $1,129,708 | $620,433 |
| 2013 | 1,354 | 9,444 | 69 | 4.15 | $931,767 | $487,622 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 43 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 92 | $141,684 | $282 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 205 | $39,535 | $94 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 119 | $29,624 | None |
| Long return visit (40+ min) | 166 | $29,109 | $82 |
| Return visit (30+ min) | 253 | $27,827 | $70 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 164 | $23,379 | $63 |
| Home dialysis services per month (20 years or older) | 14 | $20,943 | $230 |
| Parathormone (parathyroid hormone) level | 190 | $15,415 | $40 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 43 | $15,055 | $235 |
| Hemodialysis procedure with physician evaluation | 99 | $11,549 | $57 |
| Ultrasound of leg arteries or artery grafts | 58 | $11,468 | $198 |
| Vitamin d-3 level | 190 | $11,027 | $29 |
| Cystatin c (enzyme inhibitor) level | 206 | $8,334 | $18 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 56 | $7,699 | $137 |
| Insertion of needle into vein for collection of blood sample | 214 | $5,259 | $8 |
| Blood test, comprehensive group of blood chemicals | 211 | $4,877 | $10 |
| Magnesium level | 209 | $3,043 | $7 |
| Injection of drug or substance under skin or into muscle | 123 | $2,735 | $11 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 21 | $2,318 | $54 |
| Phosphate level | 209 | $2,159 | $5 |
| Complete ultrasound scan behind abdominal cavity | 24 | $2,134 | $89 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 174 | $2,024 | $6 |
| New patient visit (45+ min) | 17 | $1,906 | $112 |
| Dialysis procedure including 1 evaluation | 17 | $1,850 | $69 |
| Ferritin (blood protein) level | 51 | $1,804 | $13 |
| Blood test, lipids (cholesterol and triglycerides) | 126 | $1,797 | $13 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,244 | $96 |
| Iron binding capacity | 51 | $1,174 | $9 |
| Short return visit (20+ min) | 20 | $1,029 | $47 |
| Creatinine level to test for kidney function or muscle injury | 129 | $925 | $5 |
| Iron level | 51 | $869 | $6 |
| Cyanocobalamin (vitamin b-12) level | 34 | $709 | $15 |
| Folic acid level, serum | 33 | $706 | $14 |
| Urine microalbumin (protein) level | 85 | $577 | $6 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $472 | $39 |
| Total protein level, urine | 63 | $342 | $4 |
| Red blood cell concentration measurement | 29 | $336 | $2 |
| Blood count, hemoglobin | 29 | $336 | $2 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 29 | $274 | $8 |
| Hemoglobin a1c level | 21 | $219 | $10 |
| Red blood count automated, with additional calculations | 22 | $169 | $5 |
| Uric acid level, blood | 22 | $137 | $4 |
| Infusion, normal saline solution, 250 cc | 19 | $18 | None |
2022: 49 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 97 | $126,258 | $288 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 281 | $45,591 | $82 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 128 | $45,155 | $235 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 272 | $35,837 | $56 |
| Return visit (30+ min) | 246 | $34,816 | $93 |
| Long return visit (40+ min) | 125 | $32,081 | $135 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 111 | $27,176 | None |
| Home dialysis services per month (20 years or older) | 14 | $21,174 | $221 |
| Hemodialysis procedure with physician evaluation | 165 | $19,573 | $58 |
| Parathormone (parathyroid hormone) level | 191 | $16,025 | $41 |
| Vitamin d-3 level | 192 | $11,550 | $29 |
| Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 13 | $11,151 | $1 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 70 | $11,062 | $158 |
| Telephone medical discussion with physician, 21-30 minutes | 145 | $9,968 | $60 |
| Cystatin c (enzyme inhibitor) level | 217 | $8,543 | $18 |
| Complete ultrasound study of arm and leg arteries | 37 | $8,069 | $109 |
| Dialysis services, 1 physician visit per month (20 years or older) | 39 | $7,723 | $161 |
| Ultrasound of leg arteries or artery grafts | 32 | $6,404 | $200 |
| Blood test, comprehensive group of blood chemicals | 221 | $4,997 | $10 |
| Complete ultrasound scan behind abdominal cavity | 38 | $3,564 | $91 |
| Magnesium level | 219 | $3,138 | $7 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 21 | $2,545 | $58 |
| Dialysis procedure including 1 evaluation | 18 | $2,467 | $69 |
| Critical care, first 30-74 minutes | 13 | $2,253 | $173 |
| Phosphate level | 219 | $2,220 | $5 |
| Injection of drug or substance under skin or into muscle | 115 | $2,183 | $12 |
| Ferritin (blood protein) level | 65 | $2,005 | $13 |
| Blood test, lipids (cholesterol and triglycerides) | 129 | $1,933 | $13 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 170 | $1,924 | $6 |
| Short return visit (20+ min) | 28 | $1,718 | $61 |
| Insertion of needle into vein for collection of blood sample | 223 | $1,708 | $3 |
| Dialysis services, per day, less than full month service (20 years or older) | 14 | $1,320 | $8 |
| Iron binding capacity | 62 | $1,251 | $9 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 26 | $1,054 | $30 |
| Iron level | 62 | $926 | $6 |
| Creatinine level to test for kidney function or muscle injury | 112 | $829 | $5 |
| Cyanocobalamin (vitamin b-12) level | 36 | $775 | $15 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 15 | $758 | $38 |
| Folic acid level, serum | 34 | $740 | $15 |
| Urine microalbumin (protein) level | 83 | $616 | $6 |
| Telephone medical discussion with physician, 11-20 minutes | 12 | $455 | $38 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 38 | $369 | $8 |
| Red blood cell concentration measurement | 33 | $353 | $2 |
| Blood count, hemoglobin | 33 | $353 | $2 |
| Total protein level, urine | 53 | $290 | $4 |
| Red blood count automated, with additional calculations | 30 | $204 | $6 |
| Hemoglobin a1c level | 21 | $202 | $10 |
| Uric acid level, blood | 17 | $102 | $4 |
| Infusion, normal saline solution, 250 cc | 19 | $20 | None |
2021: 56 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 137 | $128,272 | $292 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 181 | $67,587 | $241 |
| Telephone medical discussion with physician, 21-30 minutes | 329 | $49,810 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 264 | $42,963 | $84 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 240 | $32,498 | $58 |
| Home dialysis services per month (20 years or older) | 13 | $25,429 | $233 |
| Hemodialysis procedure with physician evaluation | 157 | $20,355 | $60 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 81 | $16,914 | None |
| Dialysis services, 1 physician visit per month (20 years or older) | 75 | $14,716 | $155 |
| Return visit (30+ min) | 114 | $14,547 | $103 |
| Parathormone (parathyroid hormone) level | 195 | $14,407 | $41 |
| Long return visit (40+ min) | 75 | $13,627 | $142 |
| Vitamin d-3 level | 195 | $10,360 | $30 |
| Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 13 | $8,341 | $1 |
| Cystatin c (enzyme inhibitor) level | 213 | $7,260 | $18 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $6,846 | $163 |
| Blood test, comprehensive group of blood chemicals | 221 | $4,330 | $11 |
| Magnesium level | 221 | $2,740 | $7 |
| Critical care, first 30-74 minutes | 14 | $2,671 | $178 |
| Hemodialysis procedure requiring repeated evaluation | 12 | $2,493 | $86 |
| Dialysis procedure including 1 evaluation | 21 | $2,345 | $71 |
| Complete ultrasound scan behind abdominal cavity | 24 | $2,230 | $93 |
| New patient visit (45+ min) | 18 | $2,222 | $123 |
| New patient visit (60+ min) | 12 | $2,149 | $179 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 12 | $2,040 | $52 |
| Phosphate level | 221 | $1,948 | $5 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 168 | $1,799 | $6 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 17 | $1,735 | $62 |
| Blood test, lipids (cholesterol and triglycerides) | 123 | $1,701 | $13 |
| Ferritin (blood protein) level | 53 | $1,676 | $14 |
| Dialysis services, per day, less than full month service (20 years or older) | 11 | $1,596 | $7 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 25 | $1,494 | $42 |
| Injection of drug or substance under skin or into muscle | 83 | $1,390 | $11 |
| Insertion of needle into vein for collection of blood sample | 214 | $1,317 | $3 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; third dose | 30 | $1,256 | $42 |
| Iron binding capacity | 52 | $1,066 | $9 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 40 | $1,022 | $16 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 24 | $969 | $30 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 27 | $954 | $35 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 15 | $872 | $51 |
| Iron level | 52 | $789 | $6 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; third dose | 18 | $754 | $42 |
| Cyanocobalamin (vitamin b-12) level | 38 | $739 | $15 |
| Folic acid level, serum | 35 | $720 | $15 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; second dose | 17 | $712 | $42 |
| Short return visit (20+ min) | 13 | $696 | $50 |
| Creatinine level to test for kidney function or muscle injury | 98 | $648 | $5 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; first dose | 15 | $580 | $39 |
| Urine microalbumin (protein) level | 71 | $480 | $6 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 41 | $381 | $8 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 15 | $212 | $14 |
| Total protein level, urine | 40 | $198 | $4 |
| Red blood count automated, with additional calculations | 28 | $195 | $6 |
| Red blood cell concentration measurement | 26 | $194 | $2 |
| Blood count, hemoglobin | 26 | $194 | $2 |
| Infusion, normal saline solution, 250 cc | 16 | $14 | None |
2020: 45 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 199 | $128,758 | $222 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 185 | $44,793 | $184 |
| Telephone medical discussion with physician, 21-30 minutes | 297 | $39,150 | $84 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 120 | $33,857 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 224 | $32,338 | $81 |
| Home dialysis services per month (20 years or older) | 16 | $24,775 | $184 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 215 | $23,888 | $56 |
| Parathormone (parathyroid hormone) level | 201 | $15,499 | $41 |
| Hemodialysis procedure with physician evaluation | 126 | $12,270 | $57 |
| Vitamin d-3 level | 199 | $11,055 | $29 |
| Return visit (30+ min) | 169 | $10,961 | $57 |
| Dialysis services, 1 physician visit per month (20 years or older) | 58 | $8,771 | $141 |
| Cystatin c (enzyme inhibitor) level | 218 | $7,961 | $18 |
| Long return visit (40+ min) | 55 | $6,656 | $95 |
| Blood test, comprehensive group of blood chemicals | 219 | $4,592 | $10 |
| Magnesium level | 220 | $2,941 | $7 |
| Dialysis procedure including 1 evaluation | 18 | $2,643 | $68 |
| Complete ultrasound scan behind abdominal cavity | 26 | $2,310 | $86 |
| Injection of drug or substance under skin or into muscle | 125 | $2,308 | $11 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 191 | $2,166 | $6 |
| Phosphate level | 220 | $2,086 | $5 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $1,918 | $160 |
| Blood test, lipids (cholesterol and triglycerides) | 129 | $1,808 | $13 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 15 | $1,695 | $53 |
| Ferritin (blood protein) level | 52 | $1,677 | $14 |
| Insertion of needle into vein for collection of blood sample | 224 | $1,614 | $3 |
| Telephone medical discussion with physician, 11-20 minutes | 27 | $1,373 | $51 |
| Dialysis services, per day, less than full month service (20 years or older) | 37 | $1,325 | $6 |
| New patient visit (45+ min) | 14 | $1,175 | $84 |
| Iron binding capacity | 54 | $1,101 | $9 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 27 | $982 | $31 |
| Iron level | 54 | $815 | $6 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 22 | $777 | $35 |
| Folic acid level, serum | 30 | $759 | $15 |
| Creatinine level to test for kidney function or muscle injury | 116 | $756 | $5 |
| Cyanocobalamin (vitamin b-12) level | 33 | $689 | $15 |
| Short return visit (20+ min) | 16 | $614 | $38 |
| Urine microalbumin (protein) level | 85 | $545 | $6 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | 29 | $242 | $8 |
| Red blood cell concentration measurement | 23 | $237 | $2 |
| Blood count, hemoglobin | 23 | $237 | $2 |
| Total protein level, urine | 42 | $219 | $4 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 16 | $147 | $8 |
| Uric acid level, blood | 18 | $98 | $4 |
| Infusion, normal saline solution, 250 cc | 12 | $12 | None |
2019: 44 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 263 | $170,708 | $229 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 310 | $91,128 | $192 |
| Return visit (30+ min) | 366 | $50,390 | $77 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 315 | $49,622 | $84 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 107 | $44,373 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 306 | $40,950 | $59 |
| Dialysis services, 1 physician visit per month (20 years or older) | 105 | $20,302 | $150 |
| Home dialysis services per month (20 years or older) | 13 | $19,656 | $189 |
| Long return visit (40+ min) | 107 | $18,644 | $111 |
| Hemodialysis procedure with physician evaluation | 170 | $18,197 | $59 |
| Parathormone (parathyroid hormone) level | 214 | $17,843 | $45 |
| Complete ultrasound study of arm and leg arteries | 64 | $14,463 | $113 |
| Vitamin d-3 level | 217 | $12,926 | $32 |
| Cystatin c (enzyme inhibitor) level | 232 | $7,805 | $18 |
| Ultrasound of leg arteries or artery grafts | 32 | $6,616 | $207 |
| Blood test, comprehensive group of blood chemicals | 233 | $4,973 | $11 |
| Complete ultrasound scan behind abdominal cavity | 38 | $3,781 | $92 |
| Short return visit (20+ min) | 55 | $3,586 | $57 |
| Magnesium level | 231 | $3,113 | $7 |
| Injection of drug or substance under skin or into muscle | 108 | $3,059 | $14 |
| Hemodialysis procedure requiring repeated evaluation | 13 | $2,486 | $86 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 202 | $2,387 | $7 |
| New patient visit (60+ min) | 16 | $2,328 | $145 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 55 | $2,228 | $32 |
| Phosphate level | 232 | $2,219 | $5 |
| Blood test, lipids (cholesterol and triglycerides) | 139 | $2,143 | $15 |
| Dialysis procedure including 1 evaluation | 12 | $1,909 | $71 |
| Ferritin (blood protein) level | 45 | $1,797 | $15 |
| Insertion of needle into vein for collection of blood sample | 251 | $1,729 | $3 |
| New patient visit (45+ min) | 13 | $1,706 | $131 |
| Dialysis services, per day, less than full month service (20 years or older) | 85 | $1,673 | $6 |
| Iron binding capacity | 46 | $1,095 | $9 |
| Creatinine level to test for kidney function or muscle injury | 126 | $929 | $6 |
| Iron level | 46 | $811 | $7 |
| Folic acid level, serum | 28 | $736 | $16 |
| Cyanocobalamin (vitamin b-12) level | 27 | $689 | $16 |
| Urine microalbumin (protein) level | 80 | $604 | $6 |
| Total protein level, urine | 57 | $315 | $4 |
| Red blood cell concentration measurement | 22 | $254 | $2 |
| Blood count, hemoglobin | 22 | $254 | $2 |
| Blood test, basic group of blood chemicals (calcium, total) | 14 | $129 | $9 |
| Uric acid level, blood | 19 | $108 | $5 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 11 | $102 | $8 |
| Manual urinalysis test with examination using microscope, non-automated | 15 | $56 | $4 |
2018: 44 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 373 | $223,071 | $226 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 280 | $80,030 | $192 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 334 | $51,561 | $83 |
| Return visit (30+ min) | 390 | $51,124 | $77 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 281 | $35,467 | $59 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 90 | $28,820 | None |
| Long return visit (40+ min) | 119 | $21,441 | $107 |
| Parathormone (parathyroid hormone) level | 235 | $20,376 | $50 |
| Hemodialysis procedure with physician evaluation | 192 | $20,223 | $57 |
| Home dialysis services per month (20 years or older) | 13 | $15,295 | $184 |
| Vitamin d-3 level | 236 | $14,686 | $36 |
| Dialysis services, 1 physician visit per month (20 years or older) | 88 | $14,475 | $146 |
| Cystatin c (enzyme inhibitor) level | 248 | $7,881 | $18 |
| Complete ultrasound study of arm and leg arteries | 27 | $6,065 | $112 |
| Ultrasound of leg arteries or artery grafts | 27 | $6,026 | $223 |
| Blood test, comprehensive group of blood chemicals | 245 | $5,319 | $13 |
| Complete ultrasound scan behind abdominal cavity | 44 | $4,159 | $92 |
| Magnesium level | 247 | $3,517 | $8 |
| Short return visit (20+ min) | 58 | $3,099 | $51 |
| New patient visit (45+ min) | 25 | $2,767 | $111 |
| Phosphate level | 249 | $2,494 | $6 |
| Blood test, lipids (cholesterol and triglycerides) | 146 | $2,462 | $16 |
| Injection of drug or substance under skin or into muscle | 90 | $2,457 | $17 |
| Dialysis services, per day, less than full month service (20 years or older) | 136 | $2,133 | $6 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 191 | $2,064 | $8 |
| Ferritin (blood protein) level | 63 | $1,913 | $16 |
| Insertion of needle into vein for collection of blood sample | 270 | $1,753 | $3 |
| New patient visit (60+ min) | 11 | $1,615 | $147 |
| Iron binding capacity | 64 | $1,247 | $11 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 39 | $1,233 | $31 |
| Creatinine level to test for kidney function or muscle injury | 133 | $1,047 | $6 |
| Iron level | 64 | $924 | $8 |
| Acute hepatitis panel | 12 | $749 | $58 |
| Urine microalbumin (protein) level | 86 | $672 | $7 |
| Folic acid level, serum | 24 | $605 | $18 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 58 | $603 | $9 |
| Cyanocobalamin (vitamin b-12) level | 24 | $602 | $18 |
| Total protein level, urine | 76 | $423 | $4 |
| Measurement of complement (immune system proteins), antigen, | 12 | $377 | $15 |
| Red blood cell concentration measurement | 26 | $255 | $3 |
| Blood count, hemoglobin | 26 | $255 | $3 |
| Blood test, basic group of blood chemicals (calcium, total) | 23 | $246 | $10 |
| Uric acid level, blood | 19 | $109 | $5 |
| Manual urinalysis test with examination using microscope, non-automated | 27 | $106 | $4 |
2017: 48 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 365 | $241,092 | $227 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 335 | $101,791 | $193 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 350 | $57,819 | $84 |
| Return visit (30+ min) | 392 | $53,296 | $76 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 309 | $38,180 | $58 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 85 | $28,051 | None |
| Hemodialysis procedure with physician evaluation | 209 | $25,759 | $58 |
| Long return visit (40+ min) | 121 | $19,338 | $109 |
| Home dialysis services per month (20 years or older) | 15 | $17,923 | $185 |
| Parathormone (parathyroid hormone) level | 197 | $16,716 | $55 |
| Dialysis services, 1 physician visit per month (20 years or older) | 78 | $13,814 | $147 |
| Vitamin d-3 level | 206 | $12,374 | $40 |
| Complete ultrasound study of arm and leg arteries | 37 | $7,854 | $108 |
| Complete ultrasound scan behind abdominal cavity | 52 | $5,012 | $95 |
| Short return visit (20+ min) | 64 | $3,314 | $48 |
| New patient visit (60+ min) | 22 | $3,298 | $150 |
| Cystatin c (enzyme inhibitor) level | 130 | $3,236 | $18 |
| Dialysis procedure including 1 evaluation | 19 | $2,865 | $70 |
| New patient visit (45+ min) | 27 | $2,754 | $102 |
| Ultrasound of leg arteries or artery grafts | 13 | $2,720 | $209 |
| Injection of drug or substance under skin or into muscle | 84 | $2,661 | $21 |
| Critical care, first 30-74 minutes | 13 | $2,337 | $180 |
| Ferritin (blood protein) level | 66 | $2,108 | $18 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 46 | $2,031 | $32 |
| Hemodialysis procedure requiring repeated evaluation | 16 | $2,026 | $84 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 148 | $1,897 | $9 |
| Blood test, basic group of blood chemicals (calcium, total) | 135 | $1,696 | $10 |
| Magnesium level | 132 | $1,695 | $9 |
| Blood test, lipids (cholesterol and triglycerides) | 122 | $1,657 | $13 |
| Blood test, comprehensive group of blood chemicals | 129 | $1,620 | $9 |
| Insertion of needle into vein for collection of blood sample | 229 | $1,423 | $3 |
| Dialysis services, per day, less than full month service (20 years or older) | 69 | $1,228 | $6 |
| Iron binding capacity | 66 | $1,083 | $9 |
| Creatinine level to test for kidney function or muscle injury | 122 | $1,066 | $7 |
| Iron level | 66 | $1,001 | $9 |
| Phosphate level | 131 | $881 | $5 |
| Folic acid level, serum | 35 | $791 | $20 |
| Cyanocobalamin (vitamin b-12) level | 35 | $791 | $20 |
| Acute hepatitis panel | 12 | $712 | $59 |
| Urine microalbumin (protein) level | 73 | $684 | $8 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 49 | $564 | $10 |
| Total protein level, urine | 67 | $380 | $5 |
| Measurement of complement (immune system proteins), antigen, | 12 | $371 | $16 |
| Red blood cell concentration measurement | 28 | $340 | $3 |
| Blood count, hemoglobin | 28 | $340 | $3 |
| Kidney function blood test panel | 22 | $226 | $10 |
| Manual urinalysis test with examination using microscope, non-automated | 34 | $137 | $4 |
| Uric acid level, blood | 14 | $85 | $4 |
2016: 46 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 359 | $251,135 | $228 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 278 | $79,926 | $194 |
| Return visit (30+ min) | 392 | $51,736 | $77 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 303 | $49,748 | $83 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 313 | $44,042 | $58 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 102 | $42,469 | None |
| Hemodialysis procedure with physician evaluation | 230 | $30,173 | $59 |
| Home dialysis services per month (20 years or older) | 15 | $23,865 | $188 |
| Long return visit (40+ min) | 105 | $19,038 | $111 |
| Complete ultrasound study of arm and leg arteries | 50 | $11,570 | $116 |
| Dialysis services, 1 physician visit per month (20 years or older) | 59 | $9,799 | $151 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 43 | $7,009 | $163 |
| Parathormone (parathyroid hormone) level | 82 | $6,558 | $55 |
| Ultrasound of leg arteries or artery grafts | 35 | $5,985 | $162 |
| Complete ultrasound scan behind abdominal cavity | 52 | $4,870 | $92 |
| Vitamin d-3 level | 81 | $4,624 | $40 |
| Hemodialysis procedure requiring repeated evaluation | 16 | $4,400 | $85 |
| Short return visit (20+ min) | 74 | $4,060 | $53 |
| Injection of drug or substance under skin or into muscle | 103 | $3,927 | $21 |
| New patient visit (60+ min) | 23 | $3,558 | $155 |
| Dialysis procedure including 1 evaluation | 17 | $2,708 | $69 |
| New patient visit (45+ min) | 21 | $2,306 | $110 |
| Dialysis services, per day, less than full month service (20 years or older) | 23 | $1,962 | $6 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 46 | $1,846 | $32 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,772 | $111 |
| Ultrasound of one leg arteries or artery grafts | 11 | $1,440 | $131 |
| Cystatin c (enzyme inhibitor) level | 48 | $1,120 | $18 |
| Ferritin (blood protein) level | 33 | $1,019 | $18 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 64 | $872 | $9 |
| Kidney function blood test panel | 60 | $867 | $11 |
| Acute hepatitis panel | 11 | $699 | $64 |
| Magnesium level | 49 | $635 | $9 |
| Insertion of needle into vein for collection of blood sample | 109 | $632 | $3 |
| Folic acid level, serum | 20 | $569 | $20 |
| Blood test, comprehensive group of blood chemicals | 49 | $563 | $9 |
| Cyanocobalamin (vitamin b-12) level | 18 | $523 | $20 |
| Blood test, lipids (cholesterol and triglycerides) | 41 | $514 | $11 |
| Iron binding capacity | 27 | $421 | $9 |
| Iron level | 27 | $415 | $9 |
| Creatinine level to test for kidney function or muscle injury | 38 | $346 | $7 |
| Phosphate level | 50 | $339 | $5 |
| Urine microalbumin (protein) level | 20 | $208 | $8 |
| Total protein level, urine | 23 | $152 | $5 |
| Manual urinalysis test with examination using microscope, non-automated | 35 | $148 | $4 |
| Red blood cell concentration measurement | 12 | $120 | $3 |
| Blood count, hemoglobin | 12 | $120 | $3 |
2015: 24 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 274 | $229,765 | $228 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 322 | $50,328 | $84 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 104 | $49,613 | None |
| Return visit (30+ min) | 399 | $48,988 | $79 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 338 | $46,052 | $59 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 140 | $36,101 | $194 |
| Home dialysis services per month (20 years or older) | 19 | $28,437 | $187 |
| Hemodialysis procedure with physician evaluation | 217 | $25,826 | $59 |
| Long return visit (40+ min) | 141 | $22,508 | $113 |
| Complete ultrasound study of arm and leg arteries | 88 | $20,495 | $116 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 56 | $9,206 | $164 |
| Dialysis services, 1 physician visit per month (20 years or older) | 36 | $8,026 | $149 |
| New patient visit (45+ min) | 57 | $6,784 | $119 |
| New patient visit (60+ min) | 37 | $5,939 | $161 |
| Complete ultrasound scan behind abdominal cavity | 59 | $5,636 | $96 |
| Injection of drug or substance under skin or into muscle | 104 | $4,737 | $21 |
| Dialysis procedure including 1 evaluation | 21 | $4,587 | $69 |
| Short return visit (20+ min) | 86 | $4,304 | $47 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $2,104 | $111 |
| Hemodialysis procedure requiring repeated evaluation | 16 | $1,766 | $84 |
| Ultrasound of one leg arteries or artery grafts | 14 | $1,710 | $122 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 31 | $1,301 | $31 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 11 | $419 | $35 |
| Manual urinalysis test with examination using microscope, non-automated | 63 | $266 | $4 |
2014: 22 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 240 | $209,377 | $228 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 384 | $65,543 | $83 |
| Return visit (30+ min) | 488 | $52,170 | $78 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 106 | $45,274 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 345 | $43,217 | $58 |
| Complete ultrasound study of arm and leg arteries | 154 | $35,202 | $114 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 125 | $33,298 | $191 |
| Long return visit (40+ min) | 171 | $28,056 | $114 |
| Hemodialysis procedure with physician evaluation | 207 | $26,102 | $59 |
| Home dialysis services per month (20 years or older) | 20 | $24,414 | $188 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 66 | $10,895 | $163 |
| New patient visit (60+ min) | 54 | $8,557 | $158 |
| Dialysis services, 1 physician visit per month (20 years or older) | 36 | $6,159 | $150 |
| Short return visit (20+ min) | 98 | $5,319 | $53 |
| New patient visit (45+ min) | 42 | $4,688 | $112 |
| Injection of drug or substance under skin or into muscle | 108 | $4,248 | $21 |
| Dialysis procedure including 1 evaluation | 20 | $3,573 | $70 |
| Complete ultrasound scan behind abdominal cavity | 27 | $2,224 | $82 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,661 | $111 |
| Follow-up observation care per day, typically 35 minutes | 17 | $1,383 | $73 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 28 | $1,358 | $32 |
| Manual urinalysis test with examination using microscope, non-automated | 72 | $305 | $4 |
2013: 20 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 192 | $156,531 | $225 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 370 | $59,548 | $80 |
| Return visit (30+ min) | 492 | $53,571 | $78 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 334 | $40,745 | $56 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 128 | $39,252 | None |
| Hemodialysis procedure with physician evaluation | 217 | $28,502 | $56 |
| Long return visit (40+ min) | 158 | $24,980 | $113 |
| Home dialysis services per month (20 years or older) | 19 | $23,124 | $191 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 78 | $19,673 | $189 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 50 | $7,755 | $155 |
| New patient visit (60+ min) | 40 | $6,204 | $155 |
| Injection of drug or substance under skin or into muscle | 134 | $4,866 | $21 |
| New patient visit (45+ min) | 33 | $4,053 | $123 |
| Short return visit (20+ min) | 64 | $3,719 | $54 |
| Dialysis procedure including 1 evaluation | 18 | $3,300 | $59 |
| Dialysis services, 1 physician visit per month (20 years or older) | 14 | $2,235 | $149 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 44 | $2,108 | $31 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,731 | $108 |
| Complete ultrasound scan behind abdominal cavity | 13 | $1,104 | $85 |
| Manual urinalysis test with examination using microscope, non-automated | 57 | $239 | $4 |
Medicaid work
$41,477 in 2024
Medicaid paid $41,477 for 2,094 billed services this clinician did in 2024, up to 48 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 299 | $21,329 |
| Clinic visit/encounter, all-inclusive | 15 | $5,442 |
| Long return visit (40+ min) | 244 | $3,586 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 149 | $2,858 |
| Return visit (30+ min) | 282 | $2,678 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 326 | $2,449 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 39 | $2,272 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 336 | $552 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 147 | $146 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 94 | $99 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 59 | $32 |
| Measurement of cystatin C | 13 | $15 |
| 2024 | 2,094 | 16 | 48 | $41,477 |
| 2023 | 2,211 | 17 | 44 | $16,303 |
| 2022 | 2,008 | 14 | 37 | $14,036 |
| 2021 | 796 | 10 | 35 | $35,458 |
| 2020 | 1,765 | 15 | 37 | $56,168 |
| 2019 | 1,073 | 10 | 46 | $18,129 |
| 2018 | 2,925 | 21 | 99 | $48,065 |
See the largest Medicaid services in earlier years
2023
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 439 | $4,357 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 299 | $2,370 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 315 | $2,353 |
| Long return visit (40+ min) | 256 | $2,215 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 145 | $2,043 |
| Return visit (30+ min) | 225 | $1,224 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 105 | $969 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 58 | $653 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 132 | $118 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 14 | $0 |
| COMPREHENSIVE METABOLIC PANEL | 47 | $0 |
| Measurement of vitamin D 25 hydroxy | 12 | $0 |
2022
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 333 | $3,914 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 411 | $3,432 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 179 | $2,861 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 190 | $1,816 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 306 | $1,547 |
| Long return visit (40+ min) | 86 | $306 |
| Return visit (30+ min) | 116 | $161 |
| COMPREHENSIVE METABOLIC PANEL | 84 | $0 |
| Measurement of vitamin D 25 hydroxy | 12 | $0 |
| Measurement of cystatin C | 83 | $0 |
| Measurement of magnesium | 84 | $0 |
| Parathormone (parathyroid hormone) | 12 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 33 | $9,754 |
| Injection, doxercalciferol, 1 mcg | 87 | $9,403 |
| UNLISTED DIALYSIS PROCEDURE INPATIENT/OUTPATIENT | 131 | $8,279 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 66 | $1,808 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 127 | $1,789 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 119 | $1,674 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 146 | $1,657 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 12 | $701 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 21-30 minutes of medical discussion | 25 | $256 |
| Return visit (30+ min) | 50 | $136 |
2020
| UNLISTED DIALYSIS PROCEDURE INPATIENT/OUTPATIENT | 713 | $41,041 |
| Clinic visit/encounter, all-inclusive | 27 | $6,864 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 362 | $4,884 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 142 | $1,717 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 52 | $456 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 23 | $380 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 25 | $368 |
| Return visit (30+ min) | 45 | $284 |
| Measurement of cystatin C | 65 | $58 |
| COMPREHENSIVE METABOLIC PANEL | 65 | $35 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 67 | $34 |
| Measurement of magnesium | 65 | $23 |
2019
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 447 | $5,966 |
| UNLISTED DIALYSIS PROCEDURE INPATIENT/OUTPATIENT | 143 | $5,796 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 56 | $1,649 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 95 | $1,562 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 43 | $1,241 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 58 | $819 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 22 | $560 |
| Return visit (30+ min) | 85 | $385 |
| End-stage renal disease (ESRD) related services for dialysis less than a full month of service, per day; for patients 20 years of age and older | 66 | $116 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 58 | $34 |
2018
| Clinic visit/encounter, all-inclusive | 84 | $17,719 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 863 | $13,140 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 190 | $7,210 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 262 | $3,077 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 239 | $2,936 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 150 | $2,465 |
| End-stage renal disease (ESRD) related services for dialysis less than a full month of service, per day; for patients 20 years of age and older | 317 | $722 |
| Long return visit (40+ min) | 39 | $298 |
| Return visit (30+ min) | 181 | $200 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 57 | $125 |
| Measurement of cystatin C | 77 | $98 |
| Measurement of magnesium | 78 | $40 |
Drugs they prescribed that Part D paid
$650,535
Pharmacies billed $650,535 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
2,742 generic and 586 brand-name prescriptions · $650,535 in drug cost · 28 antibiotic prescriptions to 21 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Velphoro | 150 | $360,592 | $2,404 |
| Veltassa | 58 | $57,432 | $990 |
| Sevelamer Carbonate | 183 | $38,326 | $209 |
| Prosol | 118 | $20,959 | $178 |
| Jardiance | 22 | $18,482 | $840 |
See all 45 drugs
| Velphoro | 150 | $360,592 | $2,404 |
| Veltassa | 58 | $57,432 | $990 |
| Sevelamer Carbonate | 183 | $38,326 | $209 |
| Prosol | 118 | $20,959 | $178 |
| Jardiance | 22 | $18,482 | $840 |
| Lokelma | 15 | $12,296 | $820 |
| Farxiga | 18 | $12,137 | $674 |
| Potassium Chloride | 205 | $10,465 | $51 |
| Calcium Acetate | 103 | $10,285 | $100 |
| Cinacalcet | 36 | $9,695 | $269 |
| Sevelamer | 12 | $6,634 | $553 |
| Tacrolimus | 16 | $3,715 | $232 |
| Mycophenolate Mofetil | 22 | $3,347 | $152 |
| Furosemide | 396 | $3,328 | $8 |
| Midodrine | 22 | $3,278 | $149 |
| Calcitriol | 155 | $2,784 | $18 |
| Febuxostat | 21 | $2,762 | $132 |
| Lisinopril | 203 | $2,356 | $12 |
| Valsartan | 80 | $2,283 | $29 |
| Hydralazine | 97 | $2,274 | $23 |
| Clinolipid | 11 | $1,722 | $157 |
| Bumetanide | 17 | $1,595 | $94 |
| Metolazone | 24 | $1,575 | $66 |
| Allopurinol | 113 | $1,403 | $12 |
| Losartan | 129 | $1,144 | $9 |
| Amlodipine Besylate | 182 | $1,135 | $6 |
| Metoprolol | 55 | $1,061 | $19 |
| Minoxidil | 41 | $952 | $23 |
| Potassium Citrate Er | 11 | $830 | $75 |
| Carvedilol | 86 | $718 | $8 |
| Enalapril Maleate | 11 | $471 | $43 |
| Spironolactone | 12 | $433 | $36 |
| Loperamide | 16 | $385 | $24 |
| Atorvastatin | 43 | $362 | $8 |
| Prednisone | 43 | $352 | $8 |
| Hydrochlorothiazide | 92 | $342 | $4 |
| Triamterene-Hydrochlorothiazid | 33 | $311 | $9 |
| Vitamin D2 | 28 | $304 | $11 |
| Pravastatin | 26 | $286 | $11 |
| Clonidine | 19 | $211 | $11 |
| Omeprazole | 12 | $209 | $17 |
| Gabapentin | 12 | $181 | $15 |
| Tamsulosin | 15 | $176 | $12 |
| Metoprolol | 31 | $163 | $5 |
| Hydroxyzine | 14 | $35 | $3 |
Year by year
| 2024 | 3,328 | 639 | None | 18% | $650,535 |
| 2023 | 3,091 | 613 | None | 19% | $898,757 |
| 2022 | 3,099 | 619 | None | None | $790,369 |
| 2021 | 3,146 | 605 | 0% (0) | None | $601,102 |
| 2020 | 3,542 | 611 | None | 21% | $586,913 |
| 2019 | 3,994 | 668 | None | 20% | $584,958 |
| 2018 | 4,212 | 759 | None | None | $851,291 |
| 2017 | 4,569 | 727 | None | 35% | $1,569,752 |
| 2016 | 4,665 | 755 | 0% (18) | 33% | $1,704,519 |
| 2015 | 5,115 | 789 | 1% (28) | None | $1,702,188 |
| 2014 | 4,696 | 762 | 1% (57) | 37% | $1,283,767 |
| 2013 | 5,127 | 750 | 2% (75) | None | $1,304,998 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 45 drugs
| Velphoro | 163 | $460,788 | $2,827 |
| Renvela | 54 | $104,658 | $1,938 |
| Sevelamer Carbonate | 227 | $94,075 | $414 |
| Cinacalcet | 39 | $34,854 | $894 |
| Veltassa | 16 | $20,718 | $1,295 |
| Potassium Chloride | 190 | $10,688 | $56 |
| Prosol | 73 | $10,226 | $140 |
| Calcium Acetate | 81 | $6,906 | $85 |
| Cyclosporine | 14 | $6,391 | $456 |
| Furosemide | 408 | $5,438 | $13 |
| Clinolipid | 25 | $5,221 | $209 |
| Calcitriol | 147 | $5,081 | $35 |
| Tacrolimus | 21 | $4,597 | $219 |
| Midodrine | 25 | $3,910 | $156 |
| Metolazone | 34 | $3,504 | $103 |
| Febuxostat | 12 | $3,289 | $274 |
| Bumetanide | 29 | $3,121 | $108 |
| Lisinopril | 149 | $3,023 | $20 |
| Amlodipine Besylate | 181 | $2,850 | $16 |
| Valsartan | 56 | $2,777 | $50 |
| Hydralazine | 83 | $2,352 | $28 |
| Allopurinol | 108 | $2,335 | $22 |
| Nifedipine Er | 16 | $2,240 | $140 |
| Losartan | 96 | $1,801 | $19 |
| Metoprolol | 52 | $1,706 | $33 |
| Carvedilol | 64 | $1,129 | $18 |
| Colchicine | 15 | $1,061 | $71 |
| Sodium Polystyrene Sulfonate | 12 | $1,058 | $88 |
| Minoxidil | 21 | $961 | $46 |
| Clonidine | 20 | $779 | $39 |
| Prednisone | 28 | $617 | $22 |
| Atorvastatin | 44 | $611 | $14 |
| Pravastatin | 17 | $565 | $33 |
| Loperamide | 14 | $441 | $31 |
| Pantoprazole | 11 | $425 | $39 |
| Hydrochlorothiazide | 94 | $411 | $4 |
| Metoprolol | 32 | $384 | $12 |
| Zolpidem | 15 | $375 | $25 |
| Omeprazole | 17 | $308 | $18 |
| Triamterene-Hydrochlorothiazid | 16 | $304 | $19 |
| Famotidine | 16 | $304 | $19 |
| Lisinopril-Hydrochlorothiazide | 11 | $217 | $20 |
| Gabapentin | 16 | $213 | $13 |
| Tamsulosin | 14 | $208 | $15 |
| Vitamin D2 | 22 | $72 | $3 |
2022: 43 drugs
| Velphoro | 163 | $366,777 | $2,250 |
| Sevelamer Carbonate | 215 | $98,806 | $460 |
| Renvela | 51 | $82,756 | $1,623 |
| Lanthanum Carbonate | 26 | $41,413 | $1,593 |
| Cinacalcet | 30 | $30,794 | $1,026 |
| Prosol | 149 | $18,270 | $123 |
| Veltassa | 12 | $15,429 | $1,286 |
| Clinisol | 68 | $9,310 | $137 |
| Potassium Chloride | 174 | $8,935 | $51 |
| Calcium Acetate | 78 | $7,784 | $100 |
| Calcitriol | 192 | $6,774 | $35 |
| Midodrine | 30 | $4,758 | $159 |
| Bumetanide | 39 | $4,180 | $107 |
| Furosemide | 358 | $3,067 | $9 |
| Febuxostat | 12 | $2,761 | $230 |
| Tacrolimus | 18 | $2,729 | $152 |
| Hydralazine | 84 | $2,464 | $29 |
| Metolazone | 19 | $2,231 | $117 |
| Lisinopril | 152 | $1,833 | $12 |
| Allopurinol | 104 | $1,794 | $17 |
| Amlodipine Besylate | 177 | $1,681 | $9 |
| Nifedipine Er | 14 | $1,138 | $81 |
| Atorvastatin | 56 | $1,127 | $20 |
| Nebivolol | 12 | $1,124 | $94 |
| Valsartan | 21 | $1,082 | $52 |
| Metoprolol | 51 | $1,053 | $21 |
| Losartan | 81 | $1,029 | $13 |
| Carvedilol | 64 | $744 | $12 |
| Clonidine | 43 | $639 | $15 |
| Minoxidil | 20 | $603 | $30 |
| Omeprazole | 27 | $590 | $22 |
| Enalapril Maleate | 13 | $393 | $30 |
| Triamterene-Hydrochlorothiazid | 22 | $290 | $13 |
| Hydrochlorothiazide | 69 | $285 | $4 |
| Chlorthalidone | 12 | $269 | $22 |
| Lidocaine-Prilocaine | 12 | $253 | $21 |
| Pravastatin | 11 | $247 | $22 |
| Famotidine | 13 | $235 | $18 |
| Spironolactone | 15 | $223 | $15 |
| Gabapentin | 15 | $191 | $13 |
| Vitamin D2 | 27 | $154 | $6 |
| Metoprolol | 30 | $140 | $5 |
| Prednisone | 22 | $126 | $6 |
2021: 46 drugs
| Velphoro | 90 | $209,814 | $2,331 |
| Sevelamer Carbonate | 216 | $78,164 | $362 |
| Renvela | 25 | $64,957 | $2,598 |
| Prosol | 199 | $31,502 | $158 |
| Clinisol | 139 | $23,943 | $172 |
| Cinacalcet | 29 | $23,789 | $820 |
| Auryxia | 16 | $21,836 | $1,365 |
| Clinolipid | 48 | $11,765 | $245 |
| Calcitriol | 234 | $9,751 | $42 |
| Calcium Acetate | 66 | $8,878 | $135 |
| Potassium Chloride | 164 | $7,647 | $47 |
| Midodrine | 28 | $4,703 | $168 |
| Febuxostat | 14 | $4,175 | $298 |
| Tacrolimus | 22 | $3,353 | $152 |
| Metolazone | 22 | $2,697 | $123 |
| Bumetanide | 29 | $2,606 | $90 |
| Furosemide | 302 | $2,455 | $8 |
| Hydralazine | 90 | $2,362 | $26 |
| Potassium Citrate Er | 19 | $2,068 | $109 |
| Colchicine | 16 | $1,722 | $108 |
| Amlodipine Besylate | 208 | $1,667 | $8 |
| Lisinopril | 126 | $1,333 | $11 |
| Minoxidil | 45 | $1,321 | $29 |
| Allopurinol | 82 | $1,294 | $16 |
| Losartan | 98 | $1,287 | $13 |
| Carvedilol | 64 | $953 | $15 |
| Gentamicin Sulfate | 18 | $948 | $53 |
| Valsartan | 13 | $901 | $69 |
| Nifedipine Er | 14 | $813 | $58 |
| Pravastatin | 11 | $760 | $69 |
| Metoprolol | 34 | $729 | $21 |
| Mycophenolate Mofetil | 14 | $697 | $50 |
| Lidocaine-Prilocaine | 29 | $683 | $24 |
| Chlorthalidone | 13 | $508 | $39 |
| Megestrol Acetate | 13 | $468 | $36 |
| Triamterene-Hydrochlorothiazid | 32 | $447 | $14 |
| Atorvastatin | 29 | $444 | $15 |
| Omeprazole | 25 | $443 | $18 |
| Gabapentin | 18 | $398 | $22 |
| Hydrochlorothiazide | 63 | $344 | $5 |
| Clonidine | 42 | $333 | $8 |
| Spironolactone | 14 | $255 | $18 |
| Famotidine | 16 | $224 | $14 |
| Prednisone | 32 | $200 | $6 |
| Metoprolol | 30 | $195 | $6 |
| Vitamin D2 | 25 | $120 | $5 |
2020: 51 drugs
| Velphoro | 66 | $172,574 | $2,615 |
| Renvela | 41 | $92,635 | $2,259 |
| Sevelamer Carbonate | 179 | $54,941 | $307 |
| Clinisol | 230 | $34,434 | $150 |
| Prosol | 185 | $31,057 | $168 |
| Cinacalcet | 33 | $18,079 | $548 |
| Veltassa | 16 | $15,740 | $984 |
| Lanthanum Carbonate | 15 | $14,855 | $990 |
| Calcitriol | 290 | $12,523 | $43 |
| Auryxia | 11 | $11,464 | $1,042 |
| Potassium Chloride | 189 | $11,436 | $61 |
| Calcium Acetate | 94 | $9,530 | $101 |
| Febuxostat | 28 | $9,395 | $336 |
| Midodrine | 37 | $7,091 | $192 |
| Tacrolimus | 27 | $5,754 | $213 |
| Bumetanide | 59 | $5,366 | $91 |
| Metolazone | 27 | $4,091 | $152 |
| Furosemide | 356 | $3,216 | $9 |
| Clonidine | 15 | $2,542 | $169 |
| Lisinopril | 183 | $2,104 | $11 |
| Amlodipine Besylate | 254 | $1,986 | $8 |
| Hydralazine | 73 | $1,830 | $25 |
| Potassium Citrate Er | 15 | $1,686 | $112 |
| Mycophenolate Mofetil | 23 | $1,671 | $73 |
| Levocarnitine | 12 | $1,493 | $124 |
| Nifedipine Er | 20 | $1,428 | $71 |
| Gentamicin Sulfate | 22 | $1,317 | $60 |
| Allopurinol | 81 | $1,311 | $16 |
| Minoxidil | 41 | $1,195 | $29 |
| Losartan | 89 | $1,116 | $13 |
| Metoprolol | 39 | $902 | $23 |
| Atorvastatin | 49 | $732 | $15 |
| Sodium Polystyrene Sulfonate | 11 | $715 | $65 |
| Chlorthalidone | 14 | $681 | $49 |
| Carvedilol | 54 | $646 | $12 |
| Clonidine | 50 | $635 | $13 |
| Omeprazole | 42 | $491 | $12 |
| Triamterene-Hydrochlorothiazid | 31 | $424 | $14 |
| Pantoprazole | 23 | $408 | $18 |
| Spironolactone | 24 | $396 | $16 |
| Hydrochlorothiazide | 66 | $358 | $5 |
| Prednisone | 45 | $349 | $8 |
| Metoprolol | 56 | $323 | $6 |
| Levofloxacin | 11 | $306 | $28 |
| Famotidine | 15 | $258 | $17 |
| Benazepril | 17 | $246 | $14 |
| Gabapentin | 12 | $173 | $14 |
| Tamsulosin | 14 | $123 | $9 |
| Atenolol | 13 | $121 | $9 |
| Cyclobenzaprine | 12 | $75 | $6 |
| Zolpidem | 17 | $55 | $3 |
2019: 54 drugs
| Velphoro | 70 | $132,794 | $1,897 |
| Sevelamer Carbonate | 186 | $90,740 | $488 |
| Renvela | 44 | $75,763 | $1,722 |
| Clinisol | 292 | $48,370 | $166 |
| Prosol | 156 | $23,254 | $149 |
| Doxercalciferol | 16 | $20,081 | $1,255 |
| Uloric | 30 | $19,346 | $645 |
| Potassium Chloride | 191 | $17,032 | $89 |
| Calcitriol | 284 | $12,639 | $45 |
| Veltassa | 12 | $12,216 | $1,018 |
| Cinacalcet | 13 | $11,658 | $897 |
| Febuxostat | 15 | $8,427 | $562 |
| Calcium Acetate | 61 | $7,284 | $119 |
| Bumetanide | 49 | $5,132 | $105 |
| Midodrine | 34 | $5,011 | $147 |
| Metolazone | 39 | $4,866 | $125 |
| Furosemide | 457 | $4,672 | $10 |
| Dextrose in Water | 42 | $3,484 | $83 |
| Potassium Citrate Er | 22 | $3,000 | $136 |
| Lisinopril | 240 | $2,955 | $12 |
| Paricalcitol | 22 | $2,876 | $131 |
| Hydralazine | 76 | $2,695 | $35 |
| Amlodipine Besylate | 284 | $2,600 | $9 |
| Clonidine | 15 | $2,536 | $169 |
| Allopurinol | 107 | $2,121 | $20 |
| Metoprolol | 54 | $2,085 | $39 |
| Minoxidil | 42 | $1,481 | $35 |
| Gentamicin Sulfate | 27 | $1,480 | $55 |
| Olmesartan Medoxomil | 13 | $1,442 | $111 |
| Valsartan | 16 | $1,362 | $85 |
| Nifedipine Er | 22 | $1,350 | $61 |
| Losartan | 118 | $1,157 | $10 |
| Carvedilol | 88 | $1,046 | $12 |
| Mycophenolate Mofetil | 18 | $961 | $53 |
| Clonidine | 64 | $834 | $13 |
| Omeprazole | 41 | $789 | $19 |
| Enalapril Maleate | 28 | $781 | $28 |
| Atorvastatin | 48 | $689 | $14 |
| Pravastatin | 17 | $645 | $38 |
| Chlorthalidone | 11 | $527 | $48 |
| Metoprolol | 48 | $492 | $10 |
| Spironolactone | 25 | $491 | $20 |
| Prednisone | 56 | $473 | $8 |
| Hydrochlorothiazide | 80 | $418 | $5 |
| Pantoprazole | 19 | $404 | $21 |
| Triamterene-Hydrochlorothiazid | 29 | $384 | $13 |
| Benazepril | 17 | $295 | $17 |
| Levofloxacin | 15 | $258 | $17 |
| Sucralfate | 11 | $243 | $22 |
| Azathioprine | 14 | $208 | $15 |
| Alendronate | 20 | $173 | $9 |
| Zolpidem | 21 | $143 | $7 |
| Famotidine | 16 | $77 | $5 |
| Alprazolam | 12 | $23 | $2 |
2018: 55 drugs
| Renvela | 135 | $248,492 | $1,841 |
| Sevelamer Carbonate | 186 | $192,427 | $1,035 |
| Sensipar | 31 | $57,829 | $1,865 |
| Velphoro | 24 | $51,340 | $2,139 |
| Doxercalciferol | 28 | $36,090 | $1,289 |
| Clinisol | 236 | $34,022 | $144 |
| Prosol | 150 | $26,394 | $176 |
| Uloric | 45 | $19,536 | $434 |
| Veltassa | 14 | $12,582 | $899 |
| Calcium Acetate | 135 | $11,636 | $86 |
| Calcitriol | 241 | $10,607 | $44 |
| Intralipid | 47 | $10,584 | $225 |
| Potassium Chloride | 135 | $6,936 | $51 |
| Colcrys | 12 | $5,735 | $478 |
| Metolazone | 43 | $5,439 | $126 |
| Midodrine | 26 | $4,887 | $188 |
| Bumetanide | 31 | $3,403 | $110 |
| Lisinopril | 286 | $3,288 | $11 |
| Furosemide | 406 | $2,999 | $7 |
| Megestrol Acetate | 21 | $2,739 | $130 |
| Valsartan | 44 | $2,600 | $59 |
| Clonidine | 14 | $2,585 | $185 |
| Metoprolol | 59 | $2,243 | $38 |
| Allopurinol | 112 | $2,147 | $19 |
| Amlodipine Besylate | 270 | $2,135 | $8 |
| Potassium Citrate Er | 15 | $2,108 | $141 |
| Hydralazine | 82 | $1,803 | $22 |
| Travasol | 20 | $1,760 | $88 |
| Nifedipine Er | 23 | $1,517 | $66 |
| Mycophenolate Mofetil | 20 | $1,336 | $67 |
| Minoxidil | 63 | $1,203 | $19 |
| Dextrose in Water | 40 | $1,143 | $29 |
| Carvedilol | 123 | $1,008 | $8 |
| Clonidine | 99 | $983 | $10 |
| Atorvastatin | 64 | $947 | $15 |
| Chlorthalidone | 18 | $937 | $52 |
| Pravastatin | 11 | $904 | $82 |
| Losartan | 107 | $837 | $8 |
| Tamsulosin | 23 | $662 | $29 |
| Isosorbide Dinitrate | 11 | $600 | $55 |
| Omeprazole | 31 | $529 | $17 |
| Metoprolol | 54 | $438 | $8 |
| Enalapril Maleate | 13 | $368 | $28 |
| Triamterene-Hydrochlorothiazid | 26 | $345 | $13 |
| Pantoprazole | 23 | $342 | $15 |
| Hydrochlorothiazide | 68 | $341 | $5 |
| Prednisone | 38 | $281 | $7 |
| Benazepril | 12 | $274 | $23 |
| Levofloxacin | 17 | $208 | $12 |
| Simvastatin | 21 | $182 | $9 |
| Zolpidem | 19 | $180 | $9 |
| Gabapentin | 17 | $176 | $10 |
| Ramipril | 11 | $165 | $15 |
| Lisinopril-Hydrochlorothiazide | 12 | $88 | $7 |
| Metoclopramide | 23 | $86 | $4 |
2017: 61 drugs
| Renvela | 374 | $693,255 | $1,854 |
| Sensipar | 236 | $398,709 | $1,689 |
| Doxercalciferol | 62 | $81,714 | $1,318 |
| Prosol | 260 | $53,118 | $204 |
| Velphoro | 27 | $38,631 | $1,431 |
| Sevelamer Carbonate | 20 | $34,044 | $1,702 |
| Clinisol | 107 | $18,245 | $171 |
| Uloric | 31 | $15,820 | $510 |
| Calcium Acetate | 121 | $12,755 | $105 |
| Calcitriol | 260 | $11,705 | $45 |
| Bumetanide | 54 | $7,302 | $135 |
| Potassium Chloride | 143 | $5,969 | $42 |
| Metolazone | 49 | $5,280 | $108 |
| Intralipid | 25 | $4,278 | $171 |
| Midodrine | 36 | $4,145 | $115 |
| Paricalcitol | 14 | $3,977 | $284 |
| Megestrol Acetate | 15 | $3,377 | $225 |
| Lisinopril | 277 | $2,912 | $11 |
| Allopurinol | 138 | $2,858 | $21 |
| Tacrolimus | 14 | $2,774 | $198 |
| Metoprolol | 61 | $2,636 | $43 |
| Hydralazine | 124 | $2,559 | $21 |
| Mycophenolate Mofetil | 26 | $2,503 | $96 |
| Furosemide | 350 | $2,419 | $7 |
| Tekturna | 11 | $2,320 | $211 |
| Dextrose in Water | 44 | $1,991 | $45 |
| Amlodipine Besylate | 287 | $1,792 | $6 |
| Valsartan | 55 | $1,754 | $32 |
| Nifedipine Er | 18 | $1,611 | $90 |
| Chlorthalidone | 18 | $1,113 | $62 |
| Travasol | 13 | $1,075 | $83 |
| Fluoxetine | 13 | $1,051 | $81 |
| Gentamicin Sulfate | 15 | $900 | $60 |
| Atorvastatin | 62 | $886 | $14 |
| Carvedilol | 103 | $870 | $8 |
| Tamsulosin | 20 | $807 | $40 |
| Klor-Con Sprinkle | 13 | $804 | $62 |
| Minoxidil | 36 | $747 | $21 |
| Clonidine | 69 | $692 | $10 |
| Spironolactone | 13 | $646 | $50 |
| Lidocaine-Prilocaine | 17 | $517 | $30 |
| Losartan | 62 | $498 | $8 |
| Metoprolol | 71 | $415 | $6 |
| Omeprazole | 38 | $389 | $10 |
| Prednisone | 39 | $377 | $10 |
| Hydrochlorothiazide | 57 | $371 | $7 |
| Pantoprazole | 29 | $349 | $12 |
| Simvastatin | 39 | $328 | $8 |
| Benazepril | 30 | $257 | $9 |
| Lovastatin | 27 | $237 | $9 |
| Lactulose | 18 | $202 | $11 |
| Zolpidem | 28 | $193 | $7 |
| Hydroxyzine | 13 | $181 | $14 |
| Gabapentin | 12 | $167 | $14 |
| Ramipril | 14 | $151 | $11 |
| Levothyroxine | 13 | $135 | $10 |
| Alendronate | 13 | $131 | $10 |
| Levofloxacin | 18 | $108 | $6 |
| Warfarin | 13 | $73 | $6 |
| Metoclopramide | 20 | $57 | $3 |
| Alprazolam | 11 | $36 | $3 |
2016: 70 drugs
| Renvela | 451 | $802,163 | $1,779 |
| Sensipar | 236 | $379,411 | $1,608 |
| Doxercalciferol | 86 | $87,820 | $1,021 |
| Fosrenol | 40 | $67,149 | $1,679 |
| Renagel | 17 | $61,816 | $3,636 |
| Edecrin | 11 | $55,959 | $5,087 |
| Prosol | 89 | $23,982 | $269 |
| Velphoro | 17 | $21,134 | $1,243 |
| Calcitriol | 281 | $11,039 | $39 |
| Megestrol Acetate | 38 | $10,740 | $283 |
| Calcium Acetate | 110 | $10,254 | $93 |
| Uloric | 15 | $8,377 | $558 |
| Potassium Chloride | 154 | $8,348 | $54 |
| Clinisol | 58 | $7,710 | $133 |
| Paricalcitol | 18 | $6,613 | $367 |
| Nexium | 19 | $6,348 | $334 |
| Dextrose in Water | 45 | $5,244 | $117 |
| Colchicine | 11 | $4,374 | $398 |
| Hydralazine | 147 | $4,279 | $29 |
| Metolazone | 47 | $4,069 | $87 |
| Metoprolol | 84 | $3,920 | $47 |
| Allopurinol | 153 | $3,721 | $24 |
| Midodrine | 50 | $3,636 | $73 |
| Bumetanide | 31 | $3,526 | $114 |
| Lisinopril | 264 | $3,292 | $12 |
| Valsartan | 49 | $2,894 | $59 |
| Intralipid | 25 | $2,593 | $104 |
| Furosemide | 341 | $2,226 | $7 |
| Amlodipine Besylate | 295 | $1,955 | $7 |
| Mycophenolate Mofetil | 24 | $1,795 | $75 |
| Sodium Polystyrene Sulfonate | 14 | $1,754 | $125 |
| Minoxidil | 63 | $1,623 | $26 |
| Chlorthalidone | 31 | $1,471 | $47 |
| Atorvastatin | 59 | $1,469 | $25 |
| Carvedilol | 159 | $1,387 | $9 |
| Lidocaine-Prilocaine | 39 | $1,189 | $30 |
| Clonidine | 77 | $877 | $11 |
| Ramipril | 15 | $832 | $55 |
| Pravastatin | 16 | $832 | $52 |
| Spironolactone | 18 | $693 | $39 |
| Metoprolol | 57 | $621 | $11 |
| Enalapril Maleate | 14 | $596 | $43 |
| Nifedipine Er | 11 | $583 | $53 |
| Tamsulosin | 14 | $572 | $41 |
| Losartan | 67 | $564 | $8 |
| Omeprazole | 39 | $554 | $14 |
| Gentamicin Sulfate | 22 | $549 | $25 |
| Hydrocodone-Acetaminophen | 17 | $500 | $29 |
| Levofloxacin | 19 | $495 | $26 |
| Ranitidine | 13 | $474 | $36 |
| Nifedical Xl | 15 | $427 | $28 |
| Simvastatin | 43 | $423 | $10 |
| Prednisone | 36 | $386 | $11 |
| Klor-Con 10 | 11 | $364 | $33 |
| Benazepril | 32 | $285 | $9 |
| Hydrochlorothiazide | 47 | $241 | $5 |
| Levothyroxine | 14 | $197 | $14 |
| Pantoprazole | 11 | $195 | $18 |
| Zolpidem | 16 | $191 | $12 |
| Lovastatin | 11 | $186 | $17 |
| Alendronate | 22 | $159 | $7 |
| Gabapentin | 13 | $151 | $12 |
| Sertraline | 16 | $133 | $8 |
| Alprazolam | 23 | $131 | $6 |
| Lactulose | 15 | $128 | $9 |
| Warfarin | 16 | $104 | $6 |
| Metoclopramide | 25 | $73 | $3 |
| Citalopram Hbr | 12 | $55 | $5 |
| Sulfamethoxazole-Trimethoprim | 13 | $53 | $4 |
| Lorazepam | 11 | $32 | $3 |
2015: 70 drugs
| Renvela | 465 | $720,355 | $1,549 |
| Sensipar | 274 | $373,775 | $1,364 |
| Doxercalciferol | 72 | $116,351 | $1,616 |
| Edecrin | 30 | $70,233 | $2,341 |
| Fosrenol | 35 | $69,224 | $1,978 |
| Renagel | 24 | $61,297 | $2,554 |
| Prosol | 199 | $57,225 | $288 |
| Clinisol | 183 | $21,574 | $118 |
| Dextrose in Water | 141 | $12,609 | $89 |
| Megace Es | 15 | $12,232 | $815 |
| Calcitriol | 233 | $10,993 | $47 |
| Velphoro | 12 | $10,609 | $884 |
| Potassium Chloride | 164 | $9,621 | $59 |
| Nexium | 23 | $7,097 | $309 |
| Paricalcitol | 25 | $7,091 | $284 |
| Calcium Acetate | 67 | $7,001 | $104 |
| Dexilant | 11 | $6,980 | $635 |
| Intralipid | 55 | $6,942 | $126 |
| Metoprolol | 85 | $4,956 | $58 |
| Hydralazine | 122 | $4,953 | $41 |
| Megestrol Acetate | 17 | $4,103 | $241 |
| Valsartan | 34 | $3,996 | $118 |
| Allopurinol | 183 | $3,606 | $20 |
| Lisinopril | 265 | $3,414 | $13 |
| Metolazone | 37 | $3,383 | $91 |
| Colcrys | 16 | $3,153 | $197 |
| Midodrine | 35 | $2,400 | $69 |
| Furosemide | 346 | $2,161 | $6 |
| Amlodipine Besylate | 324 | $2,057 | $6 |
| Fenofibrate | 22 | $1,853 | $84 |
| Bumetanide | 27 | $1,606 | $59 |
| Tacrolimus | 15 | $1,442 | $96 |
| Pravastatin | 30 | $1,394 | $46 |
| Lidocaine-Prilocaine | 47 | $1,392 | $30 |
| Atorvastatin | 43 | $1,372 | $32 |
| Carvedilol | 129 | $1,248 | $10 |
| Clonidine | 90 | $1,232 | $14 |
| Minoxidil | 37 | $1,229 | $33 |
| Chlorthalidone | 21 | $1,100 | $52 |
| Enalapril Maleate | 18 | $959 | $53 |
| Spironolactone | 18 | $875 | $49 |
| Tamsulosin | 22 | $844 | $38 |
| Metoprolol | 81 | $825 | $10 |
| Hydrocodone-Acetaminophen | 26 | $777 | $30 |
| Simvastatin | 74 | $737 | $10 |
| Labetalol | 14 | $728 | $52 |
| Nifedipine Er | 13 | $726 | $56 |
| Nifedical Xl | 17 | $693 | $41 |
| Omeprazole | 51 | $660 | $13 |
| Losartan | 56 | $594 | $11 |
| Benazepril | 42 | $461 | $11 |
| Prednisone | 45 | $382 | $8 |
| Hydroxyzine | 12 | $353 | $29 |
| Ranitidine | 12 | $338 | $28 |
| Clopidogrel | 24 | $307 | $13 |
| Gentamicin Sulfate | 24 | $273 | $11 |
| Pantoprazole | 24 | $266 | $11 |
| Hydrochlorothiazide | 39 | $234 | $6 |
| Gemfibrozil | 14 | $230 | $16 |
| Ramipril | 20 | $227 | $11 |
| Azathioprine | 14 | $195 | $14 |
| Warfarin | 17 | $184 | $11 |
| Gabapentin | 24 | $180 | $7 |
| Alprazolam | 12 | $166 | $14 |
| Levofloxacin | 19 | $164 | $9 |
| Zolpidem | 20 | $159 | $8 |
| Alendronate | 16 | $137 | $9 |
| Levothyroxine | 11 | $133 | $12 |
| Metoclopramide | 13 | $92 | $7 |
| Sulfamethoxazole-Trimethoprim | 12 | $58 | $5 |
2014: 67 drugs
| Renvela | 403 | $443,348 | $1,100 |
| Sensipar | 274 | $307,108 | $1,121 |
| Hectorol | 50 | $86,292 | $1,726 |
| Doxercalciferol | 45 | $85,948 | $1,910 |
| Fosrenol | 37 | $58,854 | $1,591 |
| Prosol | 138 | $36,435 | $264 |
| Clinisol | 209 | $28,286 | $135 |
| Diovan | 55 | $19,053 | $346 |
| Sevelamer Carbonate | 13 | $12,913 | $993 |
| Calcitriol | 173 | $12,041 | $70 |
| Calcium Acetate | 80 | $11,261 | $141 |
| Paricalcitol | 19 | $10,651 | $561 |
| Megace Es | 11 | $8,516 | $774 |
| Zemplar | 13 | $8,003 | $616 |
| Potassium Chloride | 112 | $7,139 | $64 |
| Dexilant | 11 | $5,653 | $514 |
| Nexium | 21 | $5,559 | $265 |
| Hydralazine | 118 | $5,132 | $43 |
| Crestor | 13 | $4,496 | $346 |
| Metoprolol | 61 | $4,444 | $73 |
| Lisinopril | 290 | $4,318 | $15 |
| Benicar | 18 | $4,073 | $226 |
| Klor-Con 10 | 54 | $2,972 | $55 |
| Fenofibrate | 22 | $2,908 | $132 |
| Metolazone | 43 | $2,776 | $65 |
| Dextrose in Water | 62 | $2,635 | $43 |
| Amlodipine Besylate | 302 | $2,421 | $8 |
| Pravastatin | 41 | $2,148 | $52 |
| Atorvastatin | 65 | $2,064 | $32 |
| Minoxidil | 48 | $1,987 | $41 |
| Allopurinol | 167 | $1,852 | $11 |
| Clonidine | 117 | $1,576 | $13 |
| Carvedilol | 127 | $1,542 | $12 |
| Furosemide | 228 | $1,526 | $7 |
| Doxazosin Mesylate | 13 | $1,264 | $97 |
| Midodrine | 19 | $1,218 | $64 |
| Proair Hfa | 13 | $1,176 | $90 |
| Nifedipine Er | 24 | $1,105 | $46 |
| Spironolactone | 23 | $1,059 | $46 |
| Hydrocodone-Acetaminophen | 50 | $1,021 | $20 |
| Nifedical Xl | 17 | $955 | $56 |
| Chlorthalidone | 28 | $941 | $34 |
| Bumetanide | 23 | $870 | $38 |
| Metoprolol | 88 | $767 | $9 |
| Simvastatin | 72 | $744 | $10 |
| Losartan | 52 | $733 | $14 |
| Enalapril Maleate | 24 | $731 | $30 |
| Benazepril | 41 | $716 | $17 |
| Omeprazole | 52 | $696 | $13 |
| Tamsulosin | 20 | $695 | $35 |
| Lidocaine-Prilocaine | 27 | $672 | $25 |
| Prednisone | 34 | $450 | $13 |
| Warfarin | 39 | $450 | $12 |
| Gemfibrozil | 11 | $448 | $41 |
| Ramipril | 25 | $428 | $17 |
| Gentamicin Sulfate | 15 | $334 | $22 |
| Gabapentin | 21 | $304 | $14 |
| Levothyroxine | 21 | $287 | $14 |
| Ropinirole | 13 | $255 | $20 |
| Hydrochlorothiazide | 32 | $217 | $7 |
| Levofloxacin | 12 | $183 | $15 |
| Cyclobenzaprine | 12 | $143 | $12 |
| Azathioprine | 14 | $135 | $10 |
| Clopidogrel | 11 | $116 | $11 |
| Famotidine | 13 | $110 | $8 |
| Alendronate | 11 | $99 | $9 |
| Zolpidem | 14 | $94 | $7 |
2013: 72 drugs
| Renvela | 462 | $468,886 | $1,015 |
| Hectorol | 159 | $223,312 | $1,404 |
| Sensipar | 187 | $162,715 | $870 |
| Fosrenol | 58 | $89,018 | $1,535 |
| Valcyte | 14 | $46,216 | $3,301 |
| Prosol | 137 | $41,158 | $300 |
| Diovan | 92 | $29,669 | $322 |
| Clinisol | 122 | $21,877 | $179 |
| Zemplar | 28 | $20,766 | $742 |
| Calcium Acetate | 95 | $14,201 | $149 |
| Calcitriol | 177 | $13,984 | $79 |
| Renagel | 14 | $12,924 | $923 |
| Uloric | 24 | $9,910 | $413 |
| Metoprolol | 81 | $6,371 | $79 |
| Potassium Chloride | 93 | $5,253 | $56 |
| Lisinopril | 368 | $4,921 | $13 |
| Nexium | 11 | $4,437 | $403 |
| Colcrys | 12 | $4,391 | $366 |
| Fenofibrate | 21 | $3,716 | $177 |
| Klor-Con 10 | 57 | $3,713 | $65 |
| Zetia | 13 | $3,613 | $278 |
| Hydralazine | 81 | $3,470 | $43 |
| Minoxidil | 75 | $3,425 | $46 |
| Amlodipine Besylate | 308 | $3,121 | $10 |
| Benicar | 20 | $2,911 | $146 |
| Nifedipine Er | 30 | $2,708 | $90 |
| Metolazone | 45 | $2,080 | $46 |
| Atorvastatin | 54 | $2,013 | $37 |
| Carvedilol | 148 | $1,999 | $14 |
| Furosemide | 290 | $1,945 | $7 |
| Dextrose in Water | 41 | $1,869 | $46 |
| Valsartan-Hydrochlorothiazide | 13 | $1,865 | $143 |
| Nifedical Xl | 29 | $1,698 | $59 |
| Allopurinol | 177 | $1,683 | $10 |
| Clonidine | 115 | $1,668 | $15 |
| Amlodipine Besylate-Benazepril | 12 | $1,635 | $136 |
| Losartan | 52 | $1,370 | $26 |
| Chlorthalidone | 50 | $1,162 | $23 |
| Simvastatin | 88 | $1,023 | $12 |
| Pravastatin | 34 | $1,008 | $30 |
| Hydrocodone-Acetaminophen | 61 | $961 | $16 |
| Metoprolol | 94 | $841 | $9 |
| Benazepril | 37 | $717 | $19 |
| Fenofibrate | 13 | $668 | $51 |
| Gemfibrozil | 20 | $658 | $33 |
| Spironolactone | 17 | $642 | $38 |
| Gentamicin Sulfate | 28 | $631 | $23 |
| Omeprazole | 39 | $607 | $16 |
| Azathioprine | 29 | $572 | $20 |
| Ventolin Hfa | 11 | $556 | $51 |
| Tamsulosin | 20 | $553 | $28 |
| Ramipril | 14 | $532 | $38 |
| Bumetanide | 16 | $508 | $32 |
| Labetalol | 13 | $491 | $38 |
| Hydrochlorothiazide | 50 | $416 | $8 |
| Gabapentin | 19 | $413 | $22 |
| Ropinirole | 16 | $407 | $25 |
| Enalapril Maleate | 21 | $365 | $17 |
| Levofloxacin | 20 | $359 | $18 |
| Levothyroxine | 21 | $326 | $16 |
| Isosorbide Mononitrate Er | 15 | $287 | $19 |
| Lidocaine-Prilocaine | 13 | $276 | $21 |
| Prednisone | 44 | $268 | $6 |
| Hydroxyzine | 11 | $250 | $23 |
| Zolpidem | 29 | $238 | $8 |
| Warfarin | 21 | $201 | $10 |
| Metoclopramide | 22 | $148 | $7 |
| Prochlorperazine Maleate | 13 | $138 | $11 |
| Famotidine | 18 | $130 | $7 |
| Cephalexin | 17 | $107 | $6 |
| Cyclobenzaprine | 11 | $97 | $9 |
| Glipizide | 16 | $87 | $5 |
Money from drug and device companies
$248 in 2025
| 2025 | 6 | 15 | None | $248 |
| 2024 | 6 | 16 | None | $313 |
| 2023 | 6 | 23 | None | $375 |
| 2022 | 6 | 18 | None | $354 |
| 2021 | 1 | 2 | None | $26 |
| 2020 | 2 | 2 | None | $28 |
| 2019 | 3 | 4 | None | $250 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Amgen | Krystexxa | $137 | 10 payments
|
| Kyowa Kirin | Crysvita | $29 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $26 | 1 payment
|
| NxStage Medical | Nxstage System One | $20 | 1 payment
|
| GlaxoSmithKline | Trelegy Ellipta | $20 | 1 payment
|
| Genentech USA | Gazyva | $16 | 1 payment
|
See all 15 published payments
| Genentech USA | Meals · 2025-12-16 | Gazyva | $16 |
| Amgen | Meals · 2025-11-18 | Krystexxa | $18 |
| Amgen | Meals · 2025-10-28 | Krystexxa | $3 |
| Amgen | Meals · 2025-09-03 | Krystexxa | $5 |
| Amgen | Meals · 2025-08-19 | Krystexxa | $17 |
| Kyowa Kirin | Meals · 2025-08-01 | Crysvita | $29 |
| NxStage Medical | Meals · 2025-08-01 | Nxstage System One | $20 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-07-09 | Kerendia | $26 |
| Amgen | Meals · 2025-06-18 | Krystexxa | $18 |
| Amgen | Meals · 2025-04-15 | Krystexxa | $19 |
| Amgen | Meals · 2025-03-25 | Krystexxa | $3 |
| Amgen | Meals · 2025-03-04 | Krystexxa | $17 |
| GlaxoSmithKline | Meals · 2025-02-10 | Trelegy Ellipta | $20 |
| Amgen | Meals · 2025-02-04 | Krystexxa | $18 |
| Amgen | Meals · 2025-01-06 | Krystexxa | $18 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $313
| Amgen | Krystexxa | $161 | 9 payments
|
| GlaxoSmithKline | Jesduvroq | $44 | 2 payments
|
| Aurinia Pharma U.S. | Lupkynis | $41 | 2 payments
|
| Daiichi Sankyo | Injectafer | $26 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $23 | 1 payment
|
| Novartis Pharmaceuticals | None | $18 | 1 payment
|
2023: $375
| Horizon Therapeutics plc | Krystexxa | $162 | 11 payments
|
| GlaxoSmithKline | Benlysta | $123 | 7 payments
|
| Amgen | Aranesp | $42 | 2 payments
|
| Calliditas Therapeutics US | Tarpeyo | $17 | 1 payment
|
| Daiichi Sankyo | Injectafer | $16 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $16 | 1 payment
|
2022: $354
| Horizon Therapeutics plc | Krystexxa | $168 | 7 payments
|
| Amgen | Parsabiv | $87 | 5 payments
|
| Otsuka America Pharmaceutical | Jynarque | $42 | 2 payments
|
| Fresenius USA Marketing | Velphoro | $27 | 2 payments
|
| GlaxoSmithKline | Benlysta | $15 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $14 | 1 payment
|
2021: $26
| Horizon Therapeutics plc | Krystexxa | $26 | 2 payments
|
2020: $28
| AMAG Pharmaceuticals | Feraheme | $15 | 1 payment
|
| Amgen | Parsabiv | $13 | 1 payment
|
2019: $250
| Novartis Pharmaceuticals | Afinitor | $128 | 2 payments
|
| Octapharma USA | Octaplas | $102 | 1 payment
|
| Ultragenyx Pharmaceutical | Crysvita | $20 | 1 payment
|
Professional record
- NPI
- 1558339630
- Licence
- CA A81989California A81989: Current · expires 2026-12-31
- Group
- The Nephrology Group Inc · Central California Faculty Medical Group Inc
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A819890
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X)
- Mailing address
- 568 E Herndon Ave Ste 201, Fresno, CA, 93720
- NPI first listed
- 2006-03-14
- NPI last updated
- 2017-08-15
This is when the NPI record was last certified, not a medical board exam.